KFF Health News July 19, 2023
Michelle Andrews

Last week, the FDA approved Opill, the first daily oral contraceptive that will be available for sale over the counter in stores as well as online. Reproductive health advocates hailed the groundbreaking approval as a step that can help millions of people avoid pregnancy, which is unintended nearly half the time in the United States.

They long have argued that eliminating the often-time-consuming step of requiring people to get a prescription before they can get birth control pills would expand access and give people more control over their contraceptive decisions.

Advocates want the FDA approval to signal a trend.

“We hope that this is only the beginning for expanding access to a range of over-the-counter contraceptive options,” said Kelly Blanchard,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ACA (Affordable Care Act), CMS, FDA, Govt Agencies, Insurance, Patient / Consumer, Payer, Provider
Achieving Value-Based Care Through the Payvider Model
CMS proposes new guardrails on Medicare Advantage prior authorizations, marketing
Medicaid Expansion is a Red and Blue State Issue
CMS' proposed changes to Medicare Advantage: 10 things to know
Medicare Advantage Plans' Prior Auth Rules Would Be Made Public Under CMS Proposal

Share This Article